Alexza Pharmaceuticals Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Alexza Pharmaceuticals Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7091
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alexza Pharmaceuticals Inc (Alexza), a wholly owned subsidiary of Ferrer Therapeutics Inc, focuses on the research, development and commercialization of novel, proprietary products for the treatment of acute central nervous system diseases. The company develops all its products based on its own proprietary technology, Staccato system (a hand-held inhaler), which is the foundation for Adasuve (loxapine), and all other product candidates. The company’s lead product Adasuve (Staccato loxapine) is indicated for the treatment of agitation associated with schizophrenia or bipolar I disorder. The company’s pipeline products consist of AZ-002 (Staccato alprazolam) for acute repetitive seizures and AZ-007 (Staccato zaleplon) for insomnia. Alexza is headquartered in Mountain View, California, the US.

Alexza Pharmaceuticals Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alexza Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Alexza Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Alexza Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Alexza Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Alexza Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Alexza Pharmaceuticals Inc, Medical Equipment, Deal Details 10
Lee’s Pharma Enters into Licensing Agreement with Alexza Pharma 10
Equity Offering 11
Alexza Pharma Raises USD5 million in Equity Offering 11
Alexza Pharma Completes Private Placement Of Shares For US$6.4 Million 12
Alexza Pharma Completes Private Placement Of Shares For US$3 Million 13
Debt Offering 14
Alexza Pharma Completes Private Placement Of Notes Due 2027 For US$45 Million 14
Acquisition 15
Grupo Ferrer Acquires Alexza Pharma 15
Alexza Pharmaceuticals Inc – Key Competitors 18
Alexza Pharmaceuticals Inc – Key Employees 19
Alexza Pharmaceuticals Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Alexza Pharmaceuticals Inc, Medical Equipment, Key Facts 2
Alexza Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Alexza Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Alexza Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Alexza Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Alexza Pharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8
Alexza Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Lee’s Pharma Enters into Licensing Agreement with Alexza Pharma 10
Alexza Pharma Raises USD5 million in Equity Offering 11
Alexza Pharma Completes Private Placement Of Shares For US$6.4 Million 12
Alexza Pharma Completes Private Placement Of Shares For US$3 Million 13
Alexza Pharma Completes Private Placement Of Notes Due 2027 For US$45 Million 14
Grupo Ferrer Acquires Alexza Pharma 15
Alexza Pharmaceuticals Inc, Key Competitors 18
Alexza Pharmaceuticals Inc, Key Employees 19
Alexza Pharmaceuticals Inc, Subsidiaries 20

List of Figures
Alexza Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Alexza Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Alexza Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Alexza Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Alexza Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Alexza Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Alexza Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Alexza Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Alexza Pharmaceuticals Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Europa Oil & Gas (Holdings) Plc (EOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Europa Oil & Gas (Holdings) Plc (Europa Oil) is an oil and gas company that offers exploration and development services. The company's services include production and development of conventional and unconventional hydrocarbon assets. It operates its assets in East Midlands basin, Aquitain ba …
  • San Leon Energy Plc (SLE):企業の財務・戦略的SWOT分析
    Summary San Leon Energy Plc (San Leon) is an oil and gas exploration and production company. It is engaged in acquiring, exploring and developing conventional and shale oil and gas assets across Europe and North Africa. The company holds interests in Durresi Block located in offshore Albania and inc …
  • TripAdvisor Inc:企業の戦略・SWOT・財務分析
    TripAdvisor Inc - Strategy, SWOT and Corporate Finance Report Summary TripAdvisor Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Las Vegas Sands Corp:戦略・SWOT・企業財務分析
    Las Vegas Sands Corp - Strategy, SWOT and Corporate Finance Report Summary Las Vegas Sands Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Reichhold LLC 2:企業の戦略的SWOT分析
    Reichhold LLC 2 - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Hyperstone GmbH:企業の戦略的SWOT分析
    Hyperstone GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Guernsey Electricity Limited:発電所・企業SWOT分析
    Guernsey Electricity Limited - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Courtagen Life Sciences Inc-医療機器分野:企業M&A・提携分析
    Summary Courtagen Life Sciences Inc (Courtagen) is a medical device company that provides neurological treatment solutions. The company’s products include neuro-development panels, lysosomal disorder panels, syndrome panels, comprehensive epilepsy panels, focus epilepsy panels, metabolism test equip …
  • Stentys SA (STNT):企業の財務・戦略的SWOT分析
    Summary Stentys SA (Stentys) is a medical device company that designs, develops and markets self-expanding stents for the treatment of patients with acute myocardial infarction and coronary disease. The company’s products include xposition S self-applying stent, mistent biodegradable sirolimus relea …
  • Nintendo Co Ltd (7974):企業の財務・戦略的SWOT分析
    Nintendo Co Ltd (7974) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Matthews International Corp (MATW):企業の財務・戦略的SWOT分析
    Matthews International Corp (MATW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Fortinet Inc (FTNT):企業の財務・戦略的SWOT分析
    Fortinet Inc (FTNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • TE Connectivity Ltd (TEL):企業の財務・戦略的SWOT分析
    TE Connectivity Ltd (TEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Gubre Fabrikalari TAS (GUBRF):企業の財務・戦略的SWOT分析
    Summary Gubre Fabrikalari TAS (Gubre Fabrikalari) is a chemical company that manufactures and markets chemical fertilizers. The company offers solid products, liquid products, powder products, organic products and special products. Its special products include humic acid, starwet, gibbest, dengem, a …
  • Axis Bank Limited:企業の戦略・SWOT・財務情報
    Axis Bank Limited - Strategy, SWOT and Corporate Finance Report Summary Axis Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Fanuc Corp (6954):企業の財務・戦略的SWOT分析
    Fanuc Corp (6954) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • The Hartford Financial Services Group, Inc.:企業の戦略・SWOT・財務情報
    The Hartford Financial Services Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Hartford Financial Services Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Otrum AS:企業の戦略的SWOT分析
    Otrum AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • EnBW Energie Baden-Wuerttenberg AG:戦略・SWOT・企業財務分析
    EnBW Energie Baden-Wuerttenberg AG - Strategy, SWOT and Corporate Finance Report Summary EnBW Energie Baden-Wuerttenberg AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • TAG Oil Ltd (TAO):企業の財務・戦略的SWOT分析
    Summary TAG Oil Ltd (TAG Oil) is an oil and gas exploration company engaged in the production of crude oil and natural gas across Canada. The company owns and operates oil and gas properties in Surat Basin and Taranaki Basin. The Taranaki Basin is located to the North Island of New Zealand. The comp …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆